Physician profile
Guy T Selander
NPI 1982662722
$514.99
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $50.27.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $160.52 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $54.78 | 2019 | |
| Medtronic Vascular, INC. | $43.29 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $35.11 | 2019 | |
| Glaxosmithkline, LLC. | $26.87 | 2019 | |
| Lilly USA, LLC | $25.87 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.31 | 2019 | |
| Janssen Pharmaceuticals, INC | $24.14 | 2019 | |
| Amgen INC. | $17.89 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.00 | 2019 | |
| Allergan, INC. | $13.57 | 2019 | |
| Abbvie INC. | $13.09 | 2019 | |
| Abbott Laboratories | $13.08 | 2019 | |
| Hologic Sales and Service, LLC | $12.80 | 2019 | |
| Pfizer INC. | $12.46 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11.21 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Selander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.